Expression of Genes Encoding Cell Motility Proteins during Progression of Head and Neck Squamous Cell Carcinoma


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The model of head and neck squamous cell carcinoma (HNSCC) was used to study the expression of genes encoding actin-binding proteins depending on the type of cell motility. The expression of SNAIL1 and CAPN2 mRNA in HNSCC tissue was higher than in specimens of dysplastic epithelium of the larynx and hypopharynx, which can be explained by activation of mesenchymal and amoeboid types of cell motility. In biopsy material of HNSCC patients with T1-2N0M0, expression of genes responsible for actin-binding proteins differed from that of patients with pretumor pathology of the larynx and hypopharynx: expression of FSCN was lower, while expressions of EZR and CAP1 were higher. The data attest that progression of HNSCC is associated with activation of both types of cell motility and with the changes in the expression of mRNA encoding cell motility proteins.

Sobre autores

O. Cheremisina

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Rússia, Moscow

V. Novikov

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Rússia, Moscow

E. Choinzonov

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University

Email: kakurinagv@oncology.tomsk.ru
Rússia, Moscow; Tomsk

G. Kakurina

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Autor responsável pela correspondência
Email: kakurinagv@oncology.tomsk.ru
Rússia, Moscow

I. Kondakova

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Rússia, Moscow

L. Spirina

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences; Siberian State Medical University

Email: kakurinagv@oncology.tomsk.ru
Rússia, Moscow; Tomsk

E. Kolegova

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Rússia, Moscow

E. Shashova

Research Institute of Oncology, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: kakurinagv@oncology.tomsk.ru
Rússia, Moscow

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018